Algert Global LLC bought a new position in shares of Centene Co. (NYSE:CNC - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 10,105 shares of the company's stock, valued at approximately $761,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vantage Investment Partners LLC increased its position in shares of Centene by 17.1% during the third quarter. Vantage Investment Partners LLC now owns 683,817 shares of the company's stock valued at $51,478,000 after purchasing an additional 99,904 shares during the period. Diversified Trust Co raised its stake in shares of Centene by 35.8% in the 2nd quarter. Diversified Trust Co now owns 28,009 shares of the company's stock valued at $1,857,000 after buying an additional 7,385 shares in the last quarter. Comerica Bank lifted its holdings in shares of Centene by 7.3% during the 1st quarter. Comerica Bank now owns 118,597 shares of the company's stock worth $9,307,000 after acquiring an additional 8,103 shares during the period. National Pension Service increased its stake in Centene by 15.4% in the third quarter. National Pension Service now owns 1,435,482 shares of the company's stock valued at $108,063,000 after acquiring an additional 191,768 shares during the period. Finally, Cetera Investment Advisers raised its position in Centene by 526.7% in the first quarter. Cetera Investment Advisers now owns 56,230 shares of the company's stock worth $4,413,000 after purchasing an additional 47,257 shares in the last quarter. 93.63% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other news, CFO Andrew Lynn Asher acquired 17,200 shares of Centene stock in a transaction that occurred on Wednesday, November 13th. The shares were acquired at an average price of $58.14 per share, with a total value of $1,000,008.00. Following the purchase, the chief financial officer now directly owns 486,847 shares of the company's stock, valued at $28,305,284.58. The trade was a 3.66 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Sarah London acquired 4,117 shares of the company's stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $60.80 per share, for a total transaction of $250,313.60. Following the purchase, the chief executive officer now directly owns 667,229 shares in the company, valued at $40,567,523.20. This trade represents a 0.62 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 0.33% of the company's stock.
Centene Trading Up 0.1 %
Shares of NYSE:CNC traded up $0.07 during trading on Friday, hitting $60.00. 2,380,159 shares of the company's stock were exchanged, compared to its average volume of 4,044,423. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. The firm has a market cap of $30.29 billion, a P/E ratio of 10.42, a PEG ratio of 0.82 and a beta of 0.49. The firm has a 50-day moving average price of $65.11 and a two-hundred day moving average price of $69.93. Centene Co. has a 1-year low of $57.20 and a 1-year high of $81.42.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on CNC shares. Stephens reiterated an "equal weight" rating and issued a $78.00 price objective on shares of Centene in a research note on Monday, August 5th. Wells Fargo & Company dropped their price objective on Centene from $91.00 to $90.00 and set an "overweight" rating for the company in a research note on Monday, November 4th. StockNews.com lowered shares of Centene from a "strong-buy" rating to a "buy" rating in a report on Monday, October 28th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Centene from $82.00 to $87.00 and gave the company a "hold" rating in a report on Friday, August 2nd. Finally, Robert W. Baird dropped their price objective on shares of Centene from $83.00 to $66.00 and set a "neutral" rating for the company in a report on Friday, October 25th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, Centene presently has an average rating of "Moderate Buy" and an average target price of $83.92.
Get Our Latest Stock Analysis on CNC
Centene Profile
(
Free Report)
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
See Also
Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.